PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: confidence

Meningococcal B Multicomponent - Alberta Health Services

Alberta Health Services Standard # May 4, 2022 Immunization Program Standards Manual Page 1 of 5 Provincial Population and Public Health Meningococcal B Multicomponent recombinant Vaccine Biological Page Section 7: Biological Product Information Standard #: Created by: Province-wide Immunization Program, Standards and Quality Approved by: Province-wide Immunization Program, Standards and Quality Approval Date: January 1, 2015 Revised: May 4, 2022 Bexsero Manufacturer GlaxoSmithKline Inc. Biological Classification Multicomponent recombinant , adsorbed. Indications for Provincially Funded Vaccine Individuals 2 months of age and older: Pre-exposure: Individuals at high risk of invasive Meningococcal disease (IMD) due to the following underlying medical conditions: o Asplenia anatomical or functional (including sickle-cell disease). o Acquired complement deficiencies , due to receipt of the terminal complement inhibitor eculizumab (Soliris ).

5. GlaxoSmithKline Inc. (2019, February 25) Bexsero® Multicomponent meningococcal B vaccine (recombinant, adsorbed). Product Monograph. 6. National Advisory Committee on Immunization (2014 April) Advice for the Use of Multicomponent Meningococcal Serogroup B …

Fullscreen Download

Tags:

  Committees, Recombinant, Advisory, Advisory committee

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Meningococcal B Multicomponent - Alberta Health Services

Documents from same domain

Starting and Operating a Food Business in Your Home

albertahealthservices.ca

Starting and Operating a Food Business in Your Home This guide provides key information about Alberta Health Services (AHS) requirements when starting and operating a home-based food business.

  Business, Operating, Food, Starting, Food business, Starting and operating a food business

Infection Prevention and Control (IPC) Resource Manual for ...

albertahealthservices.ca

Infection Prevention and Control (IPC) Resource Manual . for . Continuing Care . ... (RP) information sheet and other information. Links in the RPAP information sheets are underlined. Click on the underlined words to access the link. ... parafluenza virus, measles virus , human metapneumovirus) Cryptococcosis (Cryptococcus neoformans ...

  Sheet, Control, Human, Prevention, Resource, Infections, Infection prevention and control, Human metapneumovirus, Metapneumovirus

Connect Care: Implementation Timeline

albertahealthservices.ca

WAVE 1 - NOVEMBER 3, 2019 1 2 3 EDMONTON ZONE Suburban acute and Combined acute and long term care sites PHARMACY, ALBERTA PUBLIC LABS & DI WAVE 3 - Sites in: Suburban Edmonton MAY 2020 4 WAVE 5 - APRIL 2021 CALGARY ZONE Foothills Medical Centre (including associated clinics

  Implementation

Measles, Mumps, Rubella Vaccine (MMR)

albertahealthservices.ca

MMR • 104511 • August 1, 2019 IMMUNIZATION Immunizealberta.ca Immunization protects you from disease. Get protected, get immunized. Vaccines make your immune system stronger by …

  Vaccine

Barthel Index of Activities of Daily Living

albertahealthservices.ca

Guidelines for the Barthel Index of Activities of Daily Living General • The Index should be used as a record of what a patient . does, NOT as a record of what a patient . could do. • The main aim is to establish degree of independence from any help, physical or verbal, however minor and for whatever reason.

  Activities, Index, Daily, Independence, Barthel, Activities of daily, Barthel index, Of independence

Care After Immunization - Infant/Child

albertahealthservices.ca

• Hold, cuddle , and comfort younger children. • To help with soreness and swelling: o Put a cool, wet cloth over the area where your child had the needle. o Encourage your child to move the arm or leg where they had the needle. • If your child has a fever, they should wear fewer layers of clothes and drink more fluids.

  Immunization, Cuddle

07.280 Meningococcal Conjugate (Group C) Vaccine ...

albertahealthservices.ca

• Starting January 1, 2015 the schedule went from 3 doses given at 2, 4 and 12 months of age to 2 doses given at 4 and 12 months of age. In addition, the use of this vaccine in high risk populations stopped as they became eligible for meningococcal quadrivalent conjugate vaccine.

  Schedule, 2015, Vaccine

Meditech OE User Manual - Alberta Health Services

albertahealthservices.ca

User Manual OE Education\Meditech User Manual Page 12 Rev. July 2016 Patient Data The Patient Data button is located at the bottom of the Process Desktop. This button displays information regarding allergy information. The information collected in this routine could i nclude (site dependent) information such as: Height and Weight Diagnosis

  Manual, User, Patients, User manual, Meditech, Meditech user manual

Ethics Framework - Alberta Health Services

albertahealthservices.ca

The ultimate goal is to embed ethics reflection and action into all aspects of health care and other services across the organization. ETHICS FRAMEWORK In this ethics framework, there are a variety of resources available to help you address any ethical questions. These resources are designed to support decision-making, and to build our collective

  Health, Making, Framework, Decision, Decision making, Action

Senior Mental Health Integrated Referral (Edmonton Zone)

albertahealthservices.ca

Seniors Mental Health Integrated Referral (Edmonton Zone) 18290(Rev2014-09) Page 1 of 3 Affix patient label within this box. Complete all sections of this form, and return by fax to only one of the following programs. Client Information (print clearly) Last Name First Name

  Health, Mental, Mental health

Related documents

The Gelsinger Case - University of Alabama at Birmingham

www.uab.edu

The Recombinant DNA Advisory Committee (RAC) at the National Institutes of Health approves a clinical protocol from the Institute for Human Gene Therapy, "Recombinant Adenovirus Gene Transfer in Adults With Partial Ornithine Transcarbamylase rOTC] Deficiency." The principal investigator is Steven E. Raper, also of the University of Pennsylvania.

  University, Committees, Alabama, Case, Birmingham, Recombinant, Advisory, University of alabama at birmingham, Recombinant dna advisory committee, The gelsinger case, Gelsinger

Guidelines on the nonclinical evaluation of vaccine ...

www.who.int

immunostimulatory moieties that are engineered by recombinant DNA technology to be an inherent part of the antigen molecule (e.g., fusion proteins) or the immunogen (e.g., vectored vaccines). In this context, it should be noted that no vaccine adjuvant is authorized in its own right, but only as a component of a particular adjuvanted vaccine.

  Recombinant, Recombinant dna

Related search queries

The Gelsinger Case, University of Alabama at Birmingham, Recombinant DNA Advisory Committee, Recombinant, Recombinant DNA